{"altmetric_id":2388277,"counts":{"readers":{"mendeley":12,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["oncoblogger"],"posts_count":1}},"selected_quotes":["Association between the #HER2 Ile655Val #polymorphism and response to #trastuzumab in women with #breast #cancer"],"citation":{"abstract":"Human epidermal growth factor receptor 2 (HER2) Ile655Val polymorphism may affect the efficacy of trastuzumab treatment of breast cancer.","abstract_source":"pubmed","altmetric_jid":"4f6fa4e83cf058f610002280","authors":["X. Han","L. Diao","Y. Xu","W. Xue","T. Ouyang","J. Li","T. Wang","Z. Fan","T. Fan","B. Lin","Y. Xie"],"doi":"10.1093\/annonc\/mdu111","first_seen_on":"2014-05-29T12:14:51+00:00","issns":["1569-8041"],"journal":"Annals of Oncology","last_mentioned_on":1401365596,"links":["http:\/\/annonc.oxfordjournals.org\/content\/25\/6\/1158.short?rss=1"],"pdf_url":"http:\/\/annonc.oxfordjournals.org\/content\/25\/6\/1158.full.pdf","pmid":"24608202","publisher":"Oxford University Press","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["neoplasms"],"title":"Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/association-between-her2-ile655val-polymorphism-response-trastuzumab-women-operable-primary-breast-c"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4507509,"mean":5.1386389830674,"rank":3059003,"this_scored_higher_than_pct":20,"this_scored_higher_than":938633,"rank_type":"exact","sample_size":4507509,"percentile":20},"similar_age_3m":{"total_number_of_other_articles":106073,"mean":7.7408176710162,"rank":71366,"this_scored_higher_than_pct":22,"this_scored_higher_than":24065,"rank_type":"exact","sample_size":106073,"percentile":22},"this_journal":{"total_number_of_other_articles":2299,"mean":5.0002915578764,"rank":1758,"this_scored_higher_than_pct":15,"this_scored_higher_than":345,"rank_type":"exact","sample_size":2299,"percentile":15},"similar_age_this_journal_3m":{"total_number_of_other_articles":76,"mean":6.3616,"rank":61,"this_scored_higher_than_pct":17,"this_scored_higher_than":13,"rank_type":"exact","sample_size":76,"percentile":17}}},"demographics":{"poster_types":{"practitioner":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Researcher":3,"Student  > Ph. D. Student":3,"Student  > Postgraduate":3,"Other":1,"Student  > Master":1,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":5,"Psychology":1,"Agricultural and Biological Sciences":2,"Biochemistry, Genetics and Molecular Biology":3,"Unspecified":1}}},"geo":{"twitter":{"IT":1},"mendeley":{"EC":1,"GB":1,"FR":1,"ES":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/oncoblogger\/status\/471987637100609537","license":"datasift","citation_ids":[2388277],"posted_on":"2014-05-29T12:13:16+00:00","author":{"name":"Oncoblogger","url":"https:\/\/paper.li\/oncoblogger\/1394190713","image":"https:\/\/pbs.twimg.com\/profile_images\/2124848055\/image_normal.jpg","description":"Independent, not sponsored tweeting about medical oncology and palliative care.","id_on_source":"oncoblogger","tweeter_id":"33449751","geo":{"lt":41.89474,"ln":12.4839,"country":"IT"},"followers":576},"tweet_id":"471987637100609537"}]}}